Researchers study whether vadadustat, an investigational therapy, could mitigate acute lung injury in COVID-19 patients
University of Texas Health Science Center at HoustonPhysicians are studying whether vadadustat, an investigational therapy, could protect the lungs of COVID-19 patients by triggering the body’s protective response to low oxygen levels in a randomized Phase II clinical trial at UTHealth.